Celldex Therapeutics, Inc. · NASDAQ:CLDX

State Street Corp reported a 5.10% stake in Celldex Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2025 · Filed Feb 9, 2026

State Street Corp reported a 5.10% stake in Celldex Therapeutics, Inc., 3,397,713 shares, as a passive investor on Dec 31, 2025. Filed Feb 9, 2026 (Schedule 13G).

Stake
5.10%
Shares
3,397,713
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
STATE STREET CORPORATION5.10%3,397,713

Source

View original at SEC

Related